Menu
Back to User profile » Dr Kenji Hashimoto
Papers published by Dr Kenji Hashimoto:
Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder
Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G
Neuropsychiatric Disease and Treatment 2019, 15:1771-1779
Published Date: 2 July 2019
Increased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary study
Beyazyüz M, Küfeciler T, Bulut L, Ünsal C, Albayrak Y, Akyol ES, Baykal S, Kuloglu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2016, 12:1261-1268
Published Date: 23 May 2016
Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M
Neuropsychiatric Disease and Treatment 2015, 11:1845-1851
Published Date: 29 July 2015
Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome
Akyol ES, Albayrak Y, Beyazyüz M, Aksoy N, Kuloglu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2015, 11:865-872
Published Date: 30 March 2015
Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:719-722
Published Date: 5 May 2014
Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study
Sasaki T, Hashimoto K, Tachibana M, Kurata T, Okawada K, Ishikawa M, Kimura H, Komatsu H, Ishikawa M, Hasegawa T, Shiina A, Hashimoto T, Kanahara N, Shiraishi T, Iyo M
Neuropsychiatric Disease and Treatment 2014, 10:147-151
Published Date: 24 January 2014
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
Ünsal C, Albayrak Y, Albayrak N, Kuloğlu M, Hashimoto K
Neuropsychiatric Disease and Treatment 2013, 9:1545-1552
Published Date: 11 October 2013
The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases
Masatomo Ishikawa, Kenji Hashimoto
Journal of Receptor, Ligand and Channel Research 2010, 3:25-36
Published Date: 16 December 2009